🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
180 Servings
Fat/Fatty Acid Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
9 Calorie(s)
Total Fat
1 Gram(s) (1% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 714mg UL 3000mg

Other Ingredients

organic Flax seed Oil Gelatin Glycerin Fish Oil purified Water Borage Oil Carob extract Mixed Tocopherols

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Children 4 or More Years of Age Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 1 soft gel, three times a day, or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Warning: If you are pregnant, nursing or taking medications, consult your healthcare professional before using this product.

This product contains ingredients derived from tuna.

Keep out of the reach of children.

🧪 Formulation Notes

Ultimate EFA is a proprietary blend of essential fatty acids from Borage, Flax and fish oils. Used as part of a healthy diet, essential fatty acids may support the body in many ways, especially cardiovascular health.

Manufactured in the U.S.A.

Essential fatty acid Blend of flax seed, borage and fish oils

Product Details

UPC / SKU 21832
DSLD Entry Date 2020-11-21
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Youngevity
DSLD ID 240049
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →